The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells

BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer death globally and new biomarkers and treatments are severely needed. METHODS: Here, we employed HCT116 and LoVo human CRC cells made resistant to either SN38 or oxaliplatin, to investigate whether altered expression of the high affini...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedraz-Cuesta, Elena, Christensen, Sandra, Jensen, Anders A., Jensen, Niels Frank, Bunch, Lennart, Romer, Maria Unni, Brünner, Nils, Stenvang, Jan, Pedersen, Stine Falsig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445981/
https://www.ncbi.nlm.nih.gov/pubmed/25981639
http://dx.doi.org/10.1186/s12885-015-1405-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445981/
https://www.ncbi.nlm.nih.gov/pubmed/25981639
http://dx.doi.org/10.1186/s12885-015-1405-8

Ejemplares similares